6801058 Usluge spoljne kontrole kvaliteta (otvoreni tender)

This tender for external quality control services for medical laboratories presents a moderate competition opportunity. A winning strategy will focus on demonstrating robust technical expertise, a strong commitment to quality assurance, and leveraging the 'Green Procurement' aspect to differentiate. Proactive engagement with the contracting authority and meticulous attention to detail in the submission are crucial.

Uncompromising Quality and Reliability in Medical Laboratory Diagnostics.

Sustainable and Responsible Service Delivery for Public Health.

Expertise in Specialized Molecular and Immunoassay Quality Control.

Provide detailed evidence of accreditations (e.g., ISO 17043), robust quality control procedures, experienced personnel, and a proven track record in the specific analytes. Emphasize accuracy, reliability, and timely reporting.

Detail specific initiatives for environmental sustainability in service delivery, such as waste reduction, energy efficiency, sustainable sourcing of materials, and eco-friendly logistics. Quantify benefits where possible.

Ensure absolute compliance with all mandatory requirements, including the ESPD and declaration of responsible persons. Clearly articulate risk mitigation strategies for service delivery and quality assurance.

While price is not explicitly mentioned as an evaluation criterion, present a competitive pricing structure that reflects the quality and expertise offered. Highlight long-term cost savings through reliable quality control.

Proactively submit formal requests for clarification regarding the absence of detailed technical capability, financial requirements, and evaluation criteria. This demonstrates engagement and allows for a more tailored and competitive bid.

Given the nature of medical laboratory services, a strong emphasis on quality assurance is paramount. Detail your quality management system, accreditations (e.g., ISO 17043), internal control processes, and how you ensure the accuracy and reliability of your external quality control schemes.

Develop a detailed and actionable plan for how your service delivery will meet and exceed the 'Green Procurement' requirement. Quantify potential environmental benefits where possible (e.g., reduced waste, lower emissions).

Explicitly detail your experience and capabilities in providing external quality control for Polyoma BK virus DNA, Parvo virus DNA, and soluble IL-2 receptor/IL-6 determination. Reference specific methodologies or proficiency testing schemes you offer for these analytes.

Ensure meticulous completion of the ESPD and the declaration regarding responsible persons. Any errors or omissions could lead to exclusion. Cross-reference with tender requirements and legal obligations.

Beyond a standalone statement, integrate sustainability into the core operational plans for service delivery. This could include sustainable packaging, energy-efficient laboratory equipment, and optimized logistics for sample collection/delivery.

This tender for external quality control services is generally well-structured with clear documentation, though it lacks explicit evaluation criteria and details on financing. The e-procurement nature and available documents are positive aspects.

The tender adheres to standard EU procurement procedures (Code: 2014/24/ES) and provides necessary documentation like ESPD and contract drafts. The CPV code is appropriate. However, the absence of explicit evaluation criteria and a missing reveal date are minor procedural gaps.

The tender is clear in its description of services (external quality control for medical laboratories) and provides a comprehensive set of required documents, including technical specifications and offer forms. The reference to 'žr. pirkimo dokumentuose' (see procurement documents) is standard practice.

Most essential information is present, including contract duration and tender validity. However, the estimated value is not disclosed, which is a significant omission for bidders. The submission deadline is provided, but its reasonableness is debatable given the complexity of preparing a bid.

The tender is conducted via e-procurement, promoting transparency. All required documents are accessible, and the criteria for exclusion are standard. There are no apparent requirements tailored to specific companies, indicating a fair process.

The tender is marked as 'E-Procurement', suggesting electronic submission is likely. However, the specific e-submission platform or URL is not explicitly mentioned. Financing information is absent, and while the contract duration is clear, the start date is not specified.

Key fields such as title, reference, organization, and CPV code are populated. The dates provided (submission deadline, opening date, tender valid) are logical and consistent. There are no indications of suspension or disputes.

The tender does not explicitly mention any green procurement, social aspects, or innovation requirements. It is not indicated as EU funded, suggesting a lack of focus on these sustainability dimensions.